-transparent.png){kind=logo}
The carbocyclic analogues of the potent and selective antiherpes agents (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU), and (E)-5-(2-bromovinyl)-2'-deoxycytidine (BVDC) were synthesized by conventional methods with use of carbocyclic 2'-deoxyuridine as starting material. C-BVDU, C-IVDU, and C-BVDC were equally selective, albeit slightly less potent, in their antiherpes action than BVDU, IVDU, and BVDC. Although resistant to degradation by pyrimidine nucleoside phosphorylases, C-BVDU did not prove more effective than BVDU in the systemic (oral, intraperitoneal) or topical treatment of HSV-1 infections in mice.
Related Publications
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
November 1984,
The International journal of applied radiation and isotopes,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
February 1983,
Journal of medicinal chemistry,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
January 1986,
Journal of medicinal chemistry,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
January 1979,
Voprosy virusologii,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
September 1988,
Journal of medicinal chemistry,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
January 1991,
Journal of medicinal chemistry,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
November 1979,
Biochemical pharmacology,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
January 1982,
The Journal of biological chemistry,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
October 1990,
Chemical & pharmaceutical bulletin,
P Herdewijn, and
E De Clercq, and
J Balzarini, and
H Vanderhaeghe
May 1989,
Journal of medicinal chemistry,
